본문 바로가기
KERD
논문KCI 등재

Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome

박영준|박성균|윤성진|이무승|정유진
한국미생물·생명공학회 (The Korean Society For Microbiology And Biotechnology)|2018.09|Journal of Microbiology and Biotechnology|제28권 제9호|pp. 1413-1425

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

STECShiga toxinHUSanimal models
주제분류생물학

초록

Shiga toxins (Stxs) are the main virulence factors expressed by the pathogenic Stx-producing bacteria, namely, Shigella dysenteriae serotype 1 and certain Escherichia coli strains. These bacteria cause widespread outbreaks of bloody diarrhea (hemorrhagic colitis) that in severe cases can progress to life-threatening systemic complications, including hemolytic uremic syndrome (HUS) characterized by the acute onset of microangiopathic hemolytic anemia and kidney dysfunction. Shiga toxicosis has a distinct pathogenesis and animal models of Stxassociated HUS have allowed us to investigate this. Since these models will also be useful for developing effective countermeasures to Stx-associated HUS, it is important to have clinically relevant animal models of this disease. Multiple studies over the last few decades have shown that mice injected with purified Stxs develop some of the pathophysiological features seen in HUS patients infected with the Stx-producing bacteria. These features are also efficiently recapitulated in a non-human primate model (baboons). In addition, rats, calves, chicks, piglets, and rabbits have been used as models to study symptoms of HUS that are characteristic of each animal. These models have been very useful for testing hypotheses about how Stx induces HUS and its neurological sequelae. In this review, we describe in detail the current knowledge about the most well-studied in vivo models of Stx-induced HUS; namely, those in mice, piglets, non-human primates, and rabbits. The aim of this review is to show how each human clinical outcome-mimicking animal model can serve as an experimental tool to promote our understanding of Stx-induced pathogenesis.

Abstract

Shiga toxins (Stxs) are the main virulence factors expressed by the pathogenic Stx-producing bacteria, namely, Shigella dysenteriae serotype 1 and certain Escherichia coli strains. These bacteria cause widespread outbreaks of bloody diarrhea (hemorrhagic colitis) that in severe cases can progress to life-threatening systemic complications, including hemolytic uremic syndrome (HUS) characterized by the acute onset of microangiopathic hemolytic anemia and kidney dysfunction. Shiga toxicosis has a distinct pathogenesis and animal models of Stxassociated HUS have allowed us to investigate this. Since these models will also be useful for developing effective countermeasures to Stx-associated HUS, it is important to have clinically relevant animal models of this disease. Multiple studies over the last few decades have shown that mice injected with purified Stxs develop some of the pathophysiological features seen in HUS patients infected with the Stx-producing bacteria. These features are also efficiently recapitulated in a non-human primate model (baboons). In addition, rats, calves, chicks, piglets, and rabbits have been used as models to study symptoms of HUS that are characteristic of each animal. These models have been very useful for testing hypotheses about how Stx induces HUS and its neurological sequelae. In this review, we describe in detail the current knowledge about the most well-studied in vivo models of Stx-induced HUS; namely, those in mice, piglets, non-human primates, and rabbits. The aim of this review is to show how each human clinical outcome-mimicking animal model can serve as an experimental tool to promote our understanding of Stx-induced pathogenesis.

참고문헌 (127)

  1. Melton-Celsa AR, "Shiga toxin (Stx) classification, structure, and function", Microbiol. Spectr., 2 (2014)
  2. Lingwood CA, "Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect", FEBS Lett., 584, pp.1879~1886 (2010)[DOI]
  3. Johannes L, "Tracing the retrograde route in protein trafficking", Cell, 135, pp.1175~1187 (2008)[DOI]
  4. Gargantini L, "Growth and puberal development in males with adreno-genital syndrome", Pediatr. Med. Chir., 11, pp.597~602 (1989)
  5. Cherla RP, "Shiga toxin 1-induced proinflammatory cytokine production is regulated by the phosphatidylinositol 3-kinase", Akt, Infect. Immun., pp.2009, 77[DOI]
  6. Lee MS, "Shiga toxins induce autophagy leading to differential signalling pathways in toxin-sensitive and toxin-resistant human cells", Cell. Microbiol., 13, pp.1479~1496 (2011)[DOI]
  7. Lee MS, "Shiga toxins as multi-functional proteins: induction of host cellular stress responses, role in pathogenesis and therapeutic applications", Toxins (Basel), 8 (2016)
  8. Lee MS, "Shiga toxins activate the NLRP3 inflammasome pathway to promote both production of the proinflammatory cytokine interleukin-1beta and apoptotic cell death", Infect. Immun., 84, pp.172~186 (2016)[DOI]
  9. 이무승, "Shiga Toxins Trigger the Secretion of Lysyl-tRNA Synthetase to Enhance Proinflammatory Responses", Journal of Microbiology and Biotechnology, 26(2), pp.432~439 (2016), 한국미생물·생명공학회[DOI]
  10. Boyce M, "Cellular response to endoplasmic reticulum stress: a matter of life or death", Cell Death Differ, 13, pp.363~373 (2006)[DOI]
  11. Yoshida H, "XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor", Cell, 107, pp.881~891 (2001)[DOI]
  12. Ron D, "Signal integration in the endoplasmic reticulum unfolded protein response", Nat. Rev. Mol. Cell Biol., 8, pp.519~529 (2007)[DOI]
  13. Oyadomari S, "Roles of CHOP", GADD153 in endoplasmic reticulum stress, 2004, pp.11, 381~389
  14. Lee SY, "Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells", Cell. Microbiol., 10, pp.770~780 (2008)[DOI]
  15. Fraser ME, "Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution", Nat. Struct. Biol., 1, pp.59~64 (1994)[DOI]
  16. Fraser ME, "Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7", J. Biol. Chem., 279, pp.27511~27517 (2004)[DOI]
  17. Trofa AF, "Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus", Clin. Infect. Dis., 29, pp.1303~1306 (1999)[DOI]
  18. Hale TL, "Shigella;Medical Microbiology" (1996)
  19. Butler T, "Haemolytic uraemic syndrome during shigellosis", Trans. R. Soc. Trop. Med. Hyg., 106, pp.395~399 (2012)[DOI]
  20. Hamano S, "Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan", Acta Paediatr., 82, pp.454~458 (1993)[DOI]
  21. Taylor CM, "Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands", Br. Med. J. (Clin. Res. Ed.), 292, pp.1513~1516 (1986)[DOI]
  22. Krogvold L, "Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children", Scand. J. Trauma Resusc. Emerg. Med., 19, pp.44~ (2011)[DOI]
  23. Upadhyaya K, "The importance of nonrenal involvement in hemolytic-uremic syndrome", Pediatrics, 65, pp.115~120 (1980)
  24. Verweyen HM, "Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria", Infection, 27, pp.341~347 (1999)[DOI]
  25. Tarr PI, "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome", Lancet, 365, pp.1073~1086 (2005)
  26. Gianantonio CA, "The hemolytic-uremic syndrome", Nephron, 11, pp.174~192 (1973)[DOI]
  27. Gyles CL, "Shiga toxin-producing Escherichia coli: an overview", J. Anim. Sci., 85, pp.E45~E62 (2007)[DOI]
  28. Eklund M, "Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles", J. Clin. Microbiol., 40, pp.4585~4593 (2002)[DOI]
  29. Tahamtan Y, "Prevalence and distribution of the stx, stx genes in Shiga toxin-producing E. coli (STEC) isolates from cattle", Iran J. Microbiol., 2, pp.8~13 (2010)
  30. Johannes L, "Shiga toxins-from cell biology to biomedical applications", Nat. Rev. Microbiol., 8, pp.105~116 (2010)[DOI]
  31. Centers for Disease C, Prevention, "Two multistate outbreaks of Shiga toxin-producing Escherichia coli infections linked to beef from a single slaughter facility - United States, 2008", MMWR Morb. Mortal. Wkly. Rep., 59, pp.557~560 (2010)
  32. Heiman KE, "Escherichia coli O157 Outbreaks in the United States, 2003-2012", Emerg. Infect. Dis., 21, pp.1293~1301 (2015)
  33. Cleary TG, "Cytotoxin-producing Escherichia coli and the hemolytic uremic syndrome", Pediatr. Clin. North Am., 35, pp.485~501 (1988)[DOI]
  34. Karmali MA, "The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli", J. Infect. Dis., 151, pp.775~782 (1985)[DOI]
  35. Loudon SE, "Blinded by Shiga toxin-producing O104 Escherichia coli and hemolytic uremic syndrome", J. Pediatr., 165, pp.410~410 (2014)[DOI]
  36. Sturm V, "Ocular involvement in paediatric haemolytic uraemic syndrome", Acta Ophthalmol., 88, pp.804~807 (2010)[DOI]
  37. Brigotti M, "Clinical relevance of Shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome", Pediatr. Infect. Dis. J., 30, pp.486~490 (2011)[DOI]
  38. Ramos MV, "Induction of neutrophil extracellular traps in Shiga toxin-associated hemolytic uremic syndrome", J. Innate Immun., 8, pp.400~411 (2016)[DOI]
  39. Leffler J, "Decreased neutrophil extracellular trap degradation in Shiga toxin-associated haemolytic uraemic syndrome", J. Innate Immun., 9, pp.12~21 (2017)[DOI]
  40. Ramegowda B, "Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines", Infect. Immun., 64, pp.1173~1180 (1996)
  41. Harrison LM, "Regulation of proinflammatory cytokine expression by Shiga toxin 1 and", or lipopolysaccharides in the human monocytic cell line THP-1, 2004, pp.72, 2618~2627
  42. Keepers TR, "A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease", J. Am. Soc. Nephrol., 17, pp.3404~3414 (2006)[DOI]
  43. Lentz EK, "Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2", Infect. Immun., 79, pp.3527~3540 (2011)[DOI]
  44. Mohawk KL, "Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection", J. Biomed. Biotechnol., 2011, pp.258185~ (2011)
  45. Coumbe A, "Nucleolar organiser regions in endometrial hyperplasia and neoplasia", Pathol. Res. Pract., 186, pp.254~259 (1990)[DOI]
  46. Lentz EK, "Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage", Infect. Immun., 78, pp.3689~3699 (2010)[DOI]
  47. Taylor FB, "Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1", Am. J. Pathol., 154, pp.1285~1299 (1999)[DOI]
  48. Cole SL, "Contribution of innate immune cells to pathogenesis of severe influenza virus infection", Clin. Sci. (Lond), 131, pp.269~283 (2017)[DOI]
  49. Greenhalgh DG, "The role of apoptosis in wound healing", Int. J. Biochem. Cell Biol., 30, pp.1019~1030 (1998)[DOI]
  50. 이무승, "Shiga Toxins Expressed by Human Pathogenic Bacteria Induce Immune Responses in Host Cells", The Journal of Microbiology, 51(6), pp.724~730 (2013), 한국미생물학회[DOI]
  51. Wadolkowski EA, "Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7", Infect. Immun., 58, pp.2438~2445 (1990)
  52. Lindgren SW, "Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model", Infect. Immun., 61, pp.3832~3842 (1993)
  53. Shimizu K, "Development of a lethal Shiga toxin-producing Escherichia coli-infection mouse model using multiple mitomycin C treatment", Microb. Pathog., 35, pp.1~9 (2003)[DOI]
  54. Isogai E, "Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain", Infect. Immun., 66, pp.197~202 (1998)
  55. Eaton KA, "Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice", Infect. Immun., 76, pp.3054~3063 (2008)[DOI]
  56. Karpman D, "The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection", J. Infect. Dis., 175, pp.611~620 (1997)[DOI]
  57. Mohawk KL, "Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB", c mice with an intact commensal flora, 2010, pp.48, 131~142
  58. Tesh VL, "Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice", Infect. Immun., 61, pp.3392~3402 (1993)
  59. Bale JF, "CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis", Am. J. Dis. Child., 134, pp.869~872 (1980)[DOI]
  60. Talarico V, "Hemolytic uremic syndrome in children", Minerva Pediatr., 68, pp.441~455 (2016)
  61. Eriksson KJ, "Acute neurology and neurophysiology of haemolytic-uraemic syndrome", Arch. Dis. Child., 84, pp.434~435 (2001)[DOI]
  62. Siegler RL, "The hemolytic uremic syndrome", Pediatr. Clin. North Am., 42, pp.1505~1529 (1995)[DOI]
  63. Cimolai N, "Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome", Pediatrics, 90, pp.616~621 (1992)
  64. Siegler RL, "A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah", Pediatrics, 94, pp.35~40 (1994)
  65. Sheth KJ, "Neurological involvement in hemolytic-uremic syndrome", Ann. Neurol., 19, pp.90~93 (1986)[DOI]
  66. Bezkorovainy A, "Ferrous iron uptake by Bifidobacterium breve", Biol. Trace Elem. Res., 20, pp.251~267 (1989)[DOI]
  67. Park JY, "Shiga toxins induce apoptosis and ER stress in human retinal pigment epithelial cells", Toxins (Basel), 9 (2017)
  68. Fujii J, "Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice", Infect. Immun., 62, pp.3447~3453 (1994)
  69. Pinto A, "Dexamethasone prevents motor deficits and neurovascular damage produced by Shiga toxin 2 and lipopolysaccharide in the mouse striatum", Neuroscience, 344, pp.25~38 (2017)[DOI]
  70. Sugatani J, "Activation of coagulation in C57BL", 6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2, 2000, pp.100, 61~72
  71. Obata F, "Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons", J. Infect. Dis., 198, pp.1398~1406 (2008)[DOI]
  72. Zotta E, "Development of an experimental hemolytic uremic syndrome in rats", Pediatr. Nephrol., 23, pp.559~567 (2008)[DOI]
  73. Boccoli J, "Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains", Brain Res., 1230, pp.320~333 (2008)[DOI]
  74. Goldstein J, "Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study", Brain Res., 1161, pp.106~115 (2007)[DOI]
  75. Rentmeester TW, "Loreclezole monotherapy in patients with partial seizures", Epilepsy Res., 11, pp.141~145 (1992)[DOI]
  76. Lucero MS, "Intraperitoneal administration of Shiga toxin 2 induced neuronal alterations and reduced the expression levels of aquaporin 1 and aquaporin 4 in rat brain", Microb. Pathog., 53, pp.87~94 (2012)[DOI]
  77. Amran MY, "Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice", PLoS One, 8, pp.e58959~ (2013)[DOI]
  78. Storniolo A, "Quercetin affects Hsp70", IRE1alpha mediated protection from death induced by endoplasmic reticulum stress, 2015, pp.2015, 645157~
  79. Sugimoto N, "Shiga toxin-2 enhances heat-shock-induced apoptotic cell death in cultured and primary glial cells", Cell Biol. Toxicol., 30, pp.289~299 (2014)[DOI]
  80. Kang G, "A monkey model for enterohemorrhagic Escherichia coli infection", J. Infect. Dis., 184, pp.206~210 (2001)[DOI]
  81. Siegler RL, "Response to single and divided doses of Shiga toxin-1 in a primate model of hemolytic uremic syndrome", J. Am. Soc. Nephrol., 12, pp.1458~1467 (2001)
  82. Siegler RL, "Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome", Pediatr. Nephrol., 18, pp.92~96 (2003)
  83. Stearns-Kurosawa DJ, "Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli Shiga toxins in non-human primate models of hemolytic uremic syndrome", Am. J. Pathol., 182, pp.1227~1238 (2013)[DOI]
  84. Stearns-Kurosawa DJ, "Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli", Infect. Immun., 78, pp.2497~2504 (2010)[DOI]
  85. Dean-Nystrom EA, "Early attachment sites for Shiga-toxigenic Escherichia coli O157:H7 in experimentally inoculated weaned calves", Appl. Environ. Microbiol., 74, pp.6378~6384 (2008)[DOI]
  86. Hamm K, "Experimental infection of calves with Escherichia coli O104:H4 outbreak strain", Sci. Rep., 6, pp.32812~ (2016)[DOI]
  87. Oanh TK, "Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid", Infect. Immun., 80, pp.469~473 (2012)[DOI]
  88. Sato T, "Improved porcine model for Shiga toxin-producing Escherichia coli infection by deprivation of colostrum feeding in newborn piglets", Anim. Sci. J., 88, pp.826~831 (2017)[DOI]
  89. Moxley RA, "Efficacy of urtoxazumab (TMA-15 humanized monoclonal antibody specific for Shiga toxin 2) against post-diarrheal neurological sequelae caused by Escherichia coli O157:H7 infection in the neonatal gnotobiotic piglet model", Toxins (Basel), 9 (2017)
  90. Tzipori S, "The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets", J. Infect. Dis., 154, pp.712~716 (1986)[DOI]
  91. Sonntag AK, "Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells", Appl. Environ. Microbiol., 71, pp.8855~8863 (2005)[DOI]
  92. Sueyoshi M, "Experimental infection of young chicks with attaching and effacing Escherichia coli", Infect. Immun., 62, pp.4066~4071 (1994)
  93. Beery JT, "Colonization of chicken cecae by Escherichia coli associated with hemorrhagic colitis", Appl. Environ. Microbiol., 49, pp.310~315 (1985)
  94. Holloway S, "Hemolytic uremic syndrome in dogs", J. Vet. Intern. Med., 7, pp.220~227 (1993)[DOI]
  95. Raife T, "Lepirudin prevents lethal effects of Shiga toxin in a canine model", Thromb. Haemost., 92, pp.387~393 (2004)[DOI]
  96. Garcia A, "Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli", J. Infect. Dis., 193, pp.1125~1134 (2006)[DOI]
  97. Garcia A, "Intravenous Shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch Belted rabbits", Microb. Infect., 10, pp.650~656 (2008)[DOI]
  98. Fujii J, "Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2", Infect. Immun., 64, pp.5053~5060 (1996)
  99. Takahashi K, "Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2", J. Neuroinflammation, 5, pp.11~ (2008)[DOI]
  100. Exeni RA, "Role of polymorphonuclear leukocytes in the pathophysiology of typical hemolytic uremic syndrome", ScientificWorldJournal, 7, pp.1155~1164 (2007)[DOI]
  101. Karve SS, "Intestinal organoids model human responses to infection by commensal and Shiga toxin-producing Escherichia coli", PLoS One, 12, pp.e0178966~ (2017)[DOI]
  102. DesRochers TM, "Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue", Infect. Immun., 83, pp.28~38 (2015)[DOI]
  103. Marquez LB, "Effects of Shiga toxin 2 on cellular regeneration mechanisms in primary and three-dimensional cultures of human renal tubular epithelial cells", Microb. Pathog., 99, pp.87~94 (2016)[DOI]
  104. Siegler R, "Hemolytic uremic syndrome; pathogenesis, treatment, and outcome", Curr. Opin. Pediatr., 17, pp.200~204 (2005)[DOI]
  105. Sutherland SM, "Acute kidney injury in children", Adv. Chronic Kidney Dis., 24, pp.380~387 (2017)[DOI]
  106. Sheoran AS, "Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants", Infect. Immun., 71, pp.3125~3130 (2003)[DOI]
  107. Lopez EL, "Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli", Antimicrob. Agents Chemother., 54, pp.239~243 (2010)[DOI]
  108. Dowling TC, "Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers", Antimicrob. Agents Chemother., 49, pp.1808~1812 (2005)[DOI]
  109. Kato M, "Identification of a wide range of motifs inhibitory to Shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane", Appl. Environ. Microbiol., 81, pp.1092~1100 (2015)[DOI]
  110. Mitsui T, "Affinity-based screening of tetravalent peptides identifies subtype-selective neutralizers of Shiga toxin 2d, a highly virulent subtype, by targeting a unique amino acid involved in its receptor recognition", Infect. Immun., 84, pp.2653~2661 (2016)[DOI]
  111. Li T, "A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo", Sci. Rep., 6, pp.21837~ (2016)[DOI]
  112. Secher T, "Retrograde trafficking inhibitor of Shiga toxins reduces morbidity and mortality of mice infected with enterohemorrhagic Escherichia coli", Antimicrob. Agents Chemother., 59, pp.5010~5013 (2015)[DOI]
  113. Spooner RA, "The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network", Biochem. J., 414, pp.471~484 (2008)[DOI]
  114. Mukhopadhyay S, "Shiga toxin-binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms", Mol. Biol. Cell., 24, pp.2311~2318 (2013)[DOI]
  115. Jandhyala DM, "Shiga toxin 2 and flagellin from Shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation", Infect. Immun., 78, pp.2984~2994 (2010)[DOI]
  116. Saenz JB, "The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response", Cell. Microbiol., 12, pp.516~529 (2010)[DOI]
  117. Jandhyala DM, "Activation of the classical mitogen-activated protein kinases is part of the Shiga toxin-induced ribotoxic stress response and may contribute to Shiga toxin-induced inflammation", Infect. Immun., 84, pp.138~148 (2015)
  118. Jandhyala DM, "A novel Zak knockout mouse with a defective ribotoxic stress response", Toxins (Basel), 8 (2016)
  119. Stone SM, "Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib", Front. Cell. Infect. Microbiol., 2, pp.135~ (2012)
  120. Pradhan S, "Shiga toxin mediated neurologic changes in murine model of disease", Front. Cell. Infect. Microbiol., 6, pp.114~ (2016)
  121. Pohl JM, "CCR2-dependent Gr1high monocytes promote kidney injury in Shiga toxin-induced hemolytic uremic syndrome in mice", Eur. J. Immunol. (2018)
  122. Hattori T, "Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin", FEBS Open Bio, 5, pp.605~614 (2015)[DOI]
  123. Locatelli M, "Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement", J. Am. Soc. Nephrol., 25, pp.1786~1798 (2014)[DOI]
  124. Goldstein J, "Angiotensin-(1-7) protects from brain damage induced by Shiga toxin 2-producing enterohemorrhagic Escherichia coli", Am. J. Physiol. Regul. Integr. Comp. Physiol., 311, pp.R1173~R1185 (2016)[DOI]
  125. Sandhu KS, "Pathogenic Shiga toxin-producing Escherichia coli in the intestine of calves", Can. J. Vet. Res., 66, pp.65~72 (2002)
  126. Best A, "Role for flagella but not intimin in the persistent infection of the gastrointestinal tissues of specific-pathogen-free chicks by Shiga toxin-negative Escherichia coli O157:H7", Infect. Immun., 73, pp.1836~1846 (2005)[DOI]
  127. Bast DJ, "Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits", Infect. Immun., 65, pp.2019~2028 (1997)

관련 논문AI추천

Host Cellular Response during Enterohaemorrhagic Escherichia coli Shiga Toxin Exposure이무승, Lee Kyung-Soo, Park Seo-Young한국미생물·생명공학회 · 한국미생물·생명공학회지2022 · 제50권 제4호Recent Advancements in Technologies to Detect Enterohaemorrhagic Escherichia coli Shiga Toxins구치완, Kim Jeongtae, Lee Jun Bong, Lee Moo-Seung, Park Jaewon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2023 · 제33권 제5호Advanced Three-Dimensional Cell Culture Models for Investigating Enterohaemorrhagic Escherichia coli Pathogenesis and Shiga Toxin-Mediated InjuryJeong Yujin, Kim Mirim, Lee Moo-Seung, Park So-Hyeon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 국내 분리 돼지 부종병 대장균의 병원성 유전자 및 시가독소 생성 검증강아름, 김원일, 서병주, 정창기, 조호성한국동물위생학회 · 한국동물위생학회지2016 · 제39권 제2호A Case of a Shiga Toxin Producing Escherichia Coli김중범, 박미선, 박용배, 이혜경, 조승학, 채현석연세대학교의과대학 · Yonsei Medical Journal2011 · 제52권 제6호Shiga Toxin Type 2 Aggravates G1/S Phase Cell Cycle Arrest, Mediating Caspase-Independent Cell Death under Hyperosmotic Conditions in the KidneyCho Hyun-Soo, Kim Chang-Ung, Kim Dae-Soo, Lee Kyung-Soo, Lee Moo-Seung, Noh Ji Heon, Park Jun-Young, Park So-Hyeon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권

이 간행물의 다른 논문 (11건)

Effects of Lactococcus lactis subsp. lactis I2 with β-Glucooligosaccharides on Growth, Innate Immunity and Streptococcosis Resistance in Olive Flounder (Paralichthys olivaceus)한현섭, Tawheed Hasan, 공인수, 장원제, 허상우, 허민도, 김신권, 김강웅, 탁진영, 김보성, 이봉주pp. 1433-1442Sustainable Production of Dihydroxybenzene Glucosides Using Immobilized Amylosucrase from Deinococcus geothermalis김태수, 송재경, Ramesh Prasad Pandey, 이헌상, PRAKASHPARAJULIpp. 1447-1456Protective Effect of Biological Osmolytes against Heat- and Chaotropic Agent-Induced Denaturation of Bacillus licheniformis γ-Glutamyl TranspeptidaseLong-Liu Lin, Tzu-Fan Wang, Yuan-Gin Lan, Min-Guan Lin, Meng-Chun Chi, Huei-Fen Lopp. 1457-1466Label-Free Rapid and Simple Detection of Exonuclease III Activity with DNA-Templated Copper Nanoclusters강종백, 이충현pp. 1467-1472Efficient Isolation and Characterization of a Cellulase Hyperproducing Mutant Strain of Trichoderma reeseiAiyong He, Zongsheng Zou, Yu Deng, Jiaxing Xu, Tingzhou Zhang, Yunying Zhaopp. 1473-1481
원문 보기